Journal of the American Statistical Association, ISSN 0162-1459, 12/2013, Volume 108, Issue 504, pp. 1162 - 1163
Journal Article
Journal of the American Statistical Association, ISSN 0162-1459, 12/2013, Volume 108, Issue 504, pp. 1162 - 1163
Journal Article
Journal of the American Statistical Association, ISSN 0162-1459, 2013, Volume 108, Issue 504, pp. 1162 - 1163
Journal Article
Journal of the American Statistical Association, ISSN 0162-1459, 09/2011, Volume 106, Issue 495, pp. 796 - 797
Journal Article
Journal of the American Statistical Association, ISSN 0162-1459, 2011, Volume 106, Issue 495, pp. 796 - 797
Journal Article
BMC Bioinformatics, ISSN 1471-2105, 05/2009, Volume 10, Issue 1, pp. 161 - 161
Background: Gene set analysis (GSA) is a widely used strategy for gene expression data analysis based on pathway knowledge. GSA focuses on sets of related...
SURVIVAL | SIGNAL | STEM-CELLS | OSTEOBLAST DIFFERENTIATION | ADENOCARCINOMA | BIOCHEMICAL RESEARCH METHODS | PROTEIN-COUPLED RECEPTORS | LEVEL | EXPRESSION DATA | FALSE DISCOVERY RATE | LUNG-CANCER | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | MATHEMATICAL & COMPUTATIONAL BIOLOGY | Lung Neoplasms - genetics | Reproducibility of Results | Oligonucleotide Array Sequence Analysis | Signal Transduction | Humans | Lung Neoplasms - metabolism | Gene Expression Profiling - methods | Models, Statistical | Gene Regulatory Networks | Algorithms | Bone Morphogenetic Protein 6 - metabolism | Bone Morphogenetic Protein 6 - genetics | Computer Simulation | Sensitivity and Specificity | Software | Usage | DNA microarrays | Cellular signal transduction | Genetic aspects | Research | Gene expression | Applications software
SURVIVAL | SIGNAL | STEM-CELLS | OSTEOBLAST DIFFERENTIATION | ADENOCARCINOMA | BIOCHEMICAL RESEARCH METHODS | PROTEIN-COUPLED RECEPTORS | LEVEL | EXPRESSION DATA | FALSE DISCOVERY RATE | LUNG-CANCER | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | MATHEMATICAL & COMPUTATIONAL BIOLOGY | Lung Neoplasms - genetics | Reproducibility of Results | Oligonucleotide Array Sequence Analysis | Signal Transduction | Humans | Lung Neoplasms - metabolism | Gene Expression Profiling - methods | Models, Statistical | Gene Regulatory Networks | Algorithms | Bone Morphogenetic Protein 6 - metabolism | Bone Morphogenetic Protein 6 - genetics | Computer Simulation | Sensitivity and Specificity | Software | Usage | DNA microarrays | Cellular signal transduction | Genetic aspects | Research | Gene expression | Applications software
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2007, Volume 356, Issue 3, pp. 217 - 226
A small population of distinctive breast-cancer cells can recapitulate an entire breast cancer when injected into immunodeficient mice. These cells express a...
SURVIVAL | MEDICINE, GENERAL & INTERNAL | METASTASIS | THERAPY | PATTERNS | IDENTIFICATION | EXPRESSION SIGNATURE | Lung Neoplasms - genetics | Prognosis | Oligonucleotide Array Sequence Analysis | Lung Neoplasms - mortality | Neoplasm Invasiveness | Humans | Hyaluronan Receptors | Male | Gene Expression Profiling | Medulloblastoma - mortality | Epithelium | Prostatic Neoplasms - mortality | CD24 Antigen | Neoplasm Metastasis | Breast Neoplasms - genetics | Prostatic Neoplasms - genetics | Breast Neoplasms - pathology | Breast Neoplasms - mortality | Female | Medulloblastoma - genetics | Breast - pathology | Breast cancer | Research | Cancer cells | Statistical analysis | Patients | Genes | Data bases
SURVIVAL | MEDICINE, GENERAL & INTERNAL | METASTASIS | THERAPY | PATTERNS | IDENTIFICATION | EXPRESSION SIGNATURE | Lung Neoplasms - genetics | Prognosis | Oligonucleotide Array Sequence Analysis | Lung Neoplasms - mortality | Neoplasm Invasiveness | Humans | Hyaluronan Receptors | Male | Gene Expression Profiling | Medulloblastoma - mortality | Epithelium | Prostatic Neoplasms - mortality | CD24 Antigen | Neoplasm Metastasis | Breast Neoplasms - genetics | Prostatic Neoplasms - genetics | Breast Neoplasms - pathology | Breast Neoplasms - mortality | Female | Medulloblastoma - genetics | Breast - pathology | Breast cancer | Research | Cancer cells | Statistical analysis | Patients | Genes | Data bases
Journal Article
Journal of the American Statistical Association, ISSN 0162-1459, 04/2019, Volume 114, Issue 526, pp. 682 - 696
It has been proposed that complex populations, such as those that arise in genomics studies, may exhibit dependencies among observations as well as among...
Graphical modeling | Generalized least squares | Sparsity | Two-group comparison | Genomics | FALSE DISCOVERY RATE | SET | GENE-EXPRESSION | SPARSE | STATISTICS & PROBABILITY | MODEL | SELECTION | Data analysis | Parameter estimation | Covariance | Dimensional analysis | Dependence | Gene expression | Statistical tests | Convergence
Graphical modeling | Generalized least squares | Sparsity | Two-group comparison | Genomics | FALSE DISCOVERY RATE | SET | GENE-EXPRESSION | SPARSE | STATISTICS & PROBABILITY | MODEL | SELECTION | Data analysis | Parameter estimation | Covariance | Dimensional analysis | Dependence | Gene expression | Statistical tests | Convergence
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2012, Volume 7, Issue 11, p. e49941
Vaccine adverse events (VAEs) are adverse bodily changes occurring after vaccination. Understanding the adverse event (AE) profiles is a crucial step to...
UNITED-STATES | MORTALITY | SIGNAL GENERATION | SAFETY | MULTIDISCIPLINARY SCIENCES | GUILLAIN-BARRE-SYNDROME | REPORTING-SYSTEM VAERS | VACCINATION | CASE-SERIES | H1N1 | CHILDHOOD | Vaccines, Inactivated - adverse effects | Vaccines, Attenuated - adverse effects | Influenza, Human - prevention & control | Humans | Influenza Vaccines - adverse effects | Influenza vaccines | Medicine, Experimental | Medical research | Influenza | Vaccination | Enrichment | Immunization | Ontology | Guillain-Barre syndrome | Disorders | Data processing | Inflammatory response | Inflammation | Vaccines | Statistical tests | Patients | Respiratory system | Swine flu | Classification | Paralysis | Comparative analysis | Bioinformatics | Combinatorial analysis | Movement disorders
UNITED-STATES | MORTALITY | SIGNAL GENERATION | SAFETY | MULTIDISCIPLINARY SCIENCES | GUILLAIN-BARRE-SYNDROME | REPORTING-SYSTEM VAERS | VACCINATION | CASE-SERIES | H1N1 | CHILDHOOD | Vaccines, Inactivated - adverse effects | Vaccines, Attenuated - adverse effects | Influenza, Human - prevention & control | Humans | Influenza Vaccines - adverse effects | Influenza vaccines | Medicine, Experimental | Medical research | Influenza | Vaccination | Enrichment | Immunization | Ontology | Guillain-Barre syndrome | Disorders | Data processing | Inflammatory response | Inflammation | Vaccines | Statistical tests | Patients | Respiratory system | Swine flu | Classification | Paralysis | Comparative analysis | Bioinformatics | Combinatorial analysis | Movement disorders
Journal Article
Biometrics, ISSN 0006-341X, 06/1999, Volume 55, Issue 2, pp. 463 - 469
This paper discusses the analysis of an extended finite mixture model where the latent classes corresponding to the mixture components for one set of observed...
Latent variables | Growth modeling | Maximum likelihood | Latent class analysis | Trajectory classes | Logistic regression | Analytical estimating | Alcohol drinking | Trajectories | Standard error | Parametric models | Modeling | Covariance matrices | Alcohols | Normativity | MATHEMATICS, APPLIED | latent variables | maximum likelihood | STATISTICS & PROBABILITY | latent class analysis | trajectory classes | growth modeling | BIOLOGY, MISCELLANEOUS | Likelihood Functions | Algorithms | Alcoholism - etiology | Humans | Adolescent | Adult | Female | Male | Models, Statistical | Alcohol Drinking - adverse effects | Biometry
Latent variables | Growth modeling | Maximum likelihood | Latent class analysis | Trajectory classes | Logistic regression | Analytical estimating | Alcohol drinking | Trajectories | Standard error | Parametric models | Modeling | Covariance matrices | Alcohols | Normativity | MATHEMATICS, APPLIED | latent variables | maximum likelihood | STATISTICS & PROBABILITY | latent class analysis | trajectory classes | growth modeling | BIOLOGY, MISCELLANEOUS | Likelihood Functions | Algorithms | Alcoholism - etiology | Humans | Adolescent | Adult | Female | Male | Models, Statistical | Alcohol Drinking - adverse effects | Biometry
Journal Article
11.
Full Text
The high burden of alcoholic cirrhosis in privately insured persons in the United States
Hepatology, ISSN 0270-9139, 09/2018, Volume 68, Issue 3, pp. 872 - 882
Alcoholic cirrhosis (AC) is a major cause of liver‐related morbidity and mortality in the United States. Rising rates of alcohol use disorders in the United...
GLOBAL BURDEN | HEPATOCELLULAR-CARCINOMA | VIRUS-INFECTION | NATIONAL EPIDEMIOLOGIC SURVEY | USE DISORDER | HEALTH-CARE | PREVALENCE | LIVER-DISEASE | CLINICAL-COURSE | GASTROENTEROLOGY & HEPATOLOGY | VIRAL-HEPATITIS | Hypertension | Cirrhosis | Liver diseases | Diagnosis | Morbidity | Alcohol use
GLOBAL BURDEN | HEPATOCELLULAR-CARCINOMA | VIRUS-INFECTION | NATIONAL EPIDEMIOLOGIC SURVEY | USE DISORDER | HEALTH-CARE | PREVALENCE | LIVER-DISEASE | CLINICAL-COURSE | GASTROENTEROLOGY & HEPATOLOGY | VIRAL-HEPATITIS | Hypertension | Cirrhosis | Liver diseases | Diagnosis | Morbidity | Alcohol use
Journal Article
Statistica Sinica, ISSN 1017-0405, 2020
Journal Article
13.
Full Text
Cell-intrinsic determinants of ibrutinib-induced apoptosis in chronic lymphocytic leukemia
Clinical Cancer Research, ISSN 1078-0432, 02/2017, Volume 23, Issue 4, pp. 1049 - 1059
Purpose: Ibrutinib, a Bruton tyrosine kinase (BTK) inhibitor, is approved for the treatment of relapsed chronic lymphocytic leukemia (CLL) and CLL with del17p....
BTK INHIBITOR IBRUTINIB | ONCOLOGY | PHASE 1B/2 | THERAPEUTIC TARGET | IN-VIVO | PCI-32765 | FOLLOW-UP | RECEPTOR | CLONAL EVOLUTION | MUTATIONS | SINGLE-ARM | Apoptosis - drug effects | Pyrimidines - administration & dosage | Humans | Biomarkers, Pharmacological | Male | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Tumor Suppressor Protein p53 - genetics | Whole Exome Sequencing | Drug Resistance, Neoplasm - genetics | Pyrazoles - administration & dosage | Pyrimidines - adverse effects | Female | Polymorphism, Single Nucleotide | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Pyrazoles - adverse effects | Tyrosine | Trisomy | Chronic lymphatic leukemia | Leukemia | p53 Protein | Immunoblotting | ZAP-70 protein | Lymphatic leukemia | B-cell receptor | Resistance factors | Bruton's tyrosine kinase | Signaling | Sensitivity | Chemotherapy | Lymphocytes B | Experimental design | Cell lines | Mutation | Protein-tyrosine kinase | Cancer | Apoptosis | apoptosis | CLL | TP53 mutations | del17p | Ibrutinib
BTK INHIBITOR IBRUTINIB | ONCOLOGY | PHASE 1B/2 | THERAPEUTIC TARGET | IN-VIVO | PCI-32765 | FOLLOW-UP | RECEPTOR | CLONAL EVOLUTION | MUTATIONS | SINGLE-ARM | Apoptosis - drug effects | Pyrimidines - administration & dosage | Humans | Biomarkers, Pharmacological | Male | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Tumor Suppressor Protein p53 - genetics | Whole Exome Sequencing | Drug Resistance, Neoplasm - genetics | Pyrazoles - administration & dosage | Pyrimidines - adverse effects | Female | Polymorphism, Single Nucleotide | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Pyrazoles - adverse effects | Tyrosine | Trisomy | Chronic lymphatic leukemia | Leukemia | p53 Protein | Immunoblotting | ZAP-70 protein | Lymphatic leukemia | B-cell receptor | Resistance factors | Bruton's tyrosine kinase | Signaling | Sensitivity | Chemotherapy | Lymphocytes B | Experimental design | Cell lines | Mutation | Protein-tyrosine kinase | Cancer | Apoptosis | apoptosis | CLL | TP53 mutations | del17p | Ibrutinib
Journal Article
Nucleic Acids Research, ISSN 0305-1048, 07/2002, Volume 30, Issue 13, pp. 2920 - 2929
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 95, Issue 5, pp. 1378 - 1390
Purpose To performed a systematic review and pooled analysis to compare clinical outcomes of stereotactic body radiation therapy (SBRT) and radiofrequency...
Radiology | Hematology, Oncology and Palliative Medicine | 4 FRACTIONS | TRIAL | HIGH-RISK PATIENTS | ONCOLOGY | INTENTION-TO-TREAT | PROSPECTIVE PHASE-II | DOSE IRRADIATION | EXPERIENCE | HYPOFRACTIONATED RADIOTHERAPY | TUMORS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CLINICAL-OUTCOMES | Catheter Ablation - mortality | Catheter Ablation - statistics & numerical data | Prevalence | Lung Neoplasms - mortality | Humans | Middle Aged | Postoperative Complications - prevention & control | Male | Carcinoma, Non-Small-Cell Lung - diagnosis | Radiosurgery - statistics & numerical data | Postoperative Complications - mortality | Radiation Pneumonitis - prevention & control | Radiation Pneumonitis - mortality | Radiation Injuries | Aged, 80 and over | Female | Risk Factors | Survival Rate | Treatment Outcome | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | Carcinoma, Non-Small-Cell Lung - therapy | Aged | Radiosurgery - mortality | Lung Neoplasms - diagnosis | Longitudinal Studies | Medical colleges | Ablation (Surgery) | Radiation | Lung cancer, Small cell | Comparative analysis | Radiotherapy | Lung cancer, Non-small cell | Medical research | Analysis | Medicine, Experimental | REVIEWS | PATIENTS | NEOPLASMS | LUNGS | RADIOLOGY AND NUCLEAR MEDICINE | ABLATION | REGRESSION ANALYSIS | RADIOTHERAPY | LOAD COLLECTOR RATIO | RADIOWAVE RADIATION | Radiofrequency ablation | Stage I | Stereotactic body radiation therapy | Non-small cell lung cancer | Medically inoperable
Radiology | Hematology, Oncology and Palliative Medicine | 4 FRACTIONS | TRIAL | HIGH-RISK PATIENTS | ONCOLOGY | INTENTION-TO-TREAT | PROSPECTIVE PHASE-II | DOSE IRRADIATION | EXPERIENCE | HYPOFRACTIONATED RADIOTHERAPY | TUMORS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CLINICAL-OUTCOMES | Catheter Ablation - mortality | Catheter Ablation - statistics & numerical data | Prevalence | Lung Neoplasms - mortality | Humans | Middle Aged | Postoperative Complications - prevention & control | Male | Carcinoma, Non-Small-Cell Lung - diagnosis | Radiosurgery - statistics & numerical data | Postoperative Complications - mortality | Radiation Pneumonitis - prevention & control | Radiation Pneumonitis - mortality | Radiation Injuries | Aged, 80 and over | Female | Risk Factors | Survival Rate | Treatment Outcome | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | Carcinoma, Non-Small-Cell Lung - therapy | Aged | Radiosurgery - mortality | Lung Neoplasms - diagnosis | Longitudinal Studies | Medical colleges | Ablation (Surgery) | Radiation | Lung cancer, Small cell | Comparative analysis | Radiotherapy | Lung cancer, Non-small cell | Medical research | Analysis | Medicine, Experimental | REVIEWS | PATIENTS | NEOPLASMS | LUNGS | RADIOLOGY AND NUCLEAR MEDICINE | ABLATION | REGRESSION ANALYSIS | RADIOTHERAPY | LOAD COLLECTOR RATIO | RADIOWAVE RADIATION | Radiofrequency ablation | Stage I | Stereotactic body radiation therapy | Non-small cell lung cancer | Medically inoperable
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2019, Volume 14, Issue 1, p. e0207898
Influenza is a major cause of morbidity and mortality worldwide. However, vaccine effectiveness has been low to moderate in recent years and vaccine coverage...
MULTIDISCIPLINARY SCIENCES | RHINOVIRUS | INFANTS | NASOPHARYNGEAL PNEUMOCOCCAL DENSITY | SYNCYTIAL VIRUS | SEVERITY | CHILDREN | Prevention | Influenza vaccines | Usage | Microbiota (Symbiotic organisms) | Influenza | Physiological aspects | Development and progression | Research | Risk factors | Microbial activity | Pneumonia | Communities | Taxonomy | Microbiomes | Ear diseases | Viruses | Systematic review | Infections | Vaccines | Epidemiology | Immunity | Streptococcus infections | Respiratory tract | Microbiota | Microorganisms | Throats | Nose | Children | Public health | Community structure | Young adults | Households | Epithelium | Pharynx | Morbidity | Studies | Antibiotics | Relative abundance | Adults
MULTIDISCIPLINARY SCIENCES | RHINOVIRUS | INFANTS | NASOPHARYNGEAL PNEUMOCOCCAL DENSITY | SYNCYTIAL VIRUS | SEVERITY | CHILDREN | Prevention | Influenza vaccines | Usage | Microbiota (Symbiotic organisms) | Influenza | Physiological aspects | Development and progression | Research | Risk factors | Microbial activity | Pneumonia | Communities | Taxonomy | Microbiomes | Ear diseases | Viruses | Systematic review | Infections | Vaccines | Epidemiology | Immunity | Streptococcus infections | Respiratory tract | Microbiota | Microorganisms | Throats | Nose | Children | Public health | Community structure | Young adults | Households | Epithelium | Pharynx | Morbidity | Studies | Antibiotics | Relative abundance | Adults
Journal Article
Kidney International, ISSN 0085-2538, 01/2012, Volume 81, Issue 1, pp. 40 - 55
Podocyte depletion is a major mechanism driving glomerulosclerosis. Progression is the process by which progressive glomerulosclerosis leads to end stage...
glomerulosclerosis | proteinuria | renin–angiotensin system | podocyte | renin-angiotensin system | MESSENGER-RNA EXPRESSION | VIABLE PODOCYTES | URINARY-EXCRETION | HUMAN DIABETIC-NEPHROPATHY | RENAL-DISEASE | RECEPTOR BLOCKER | ACQUIRED PROTEINURIC DISEASES | HIV-ASSOCIATED NEPHROPATHY | UROLOGY & NEPHROLOGY | NEPHRIN EXPRESSION | FOCAL SEGMENTAL GLOMERULOSCLEROSIS | Antihypertensive Agents - pharmacology | Podocytes - metabolism | Angiotensin II - metabolism | Rats, Transgenic | Membrane Proteins - genetics | Humans | Kidney Failure, Chronic - drug therapy | RNA, Messenger - genetics | Rats, Inbred F344 | Angiotensin II - antagonists & inhibitors | Rats | Male | Kidney Glomerulus - pathology | Podocytes - pathology | RNA, Messenger - metabolism | Rats, Sprague-Dawley | Kidney Failure, Chronic - metabolism | Kidney Failure, Chronic - genetics | Animals | Podocytes - drug effects | Kidney Failure, Chronic - pathology | Kidney Glomerulus - metabolism | Intracellular Signaling Peptides and Proteins - genetics | Disease Models, Animal
glomerulosclerosis | proteinuria | renin–angiotensin system | podocyte | renin-angiotensin system | MESSENGER-RNA EXPRESSION | VIABLE PODOCYTES | URINARY-EXCRETION | HUMAN DIABETIC-NEPHROPATHY | RENAL-DISEASE | RECEPTOR BLOCKER | ACQUIRED PROTEINURIC DISEASES | HIV-ASSOCIATED NEPHROPATHY | UROLOGY & NEPHROLOGY | NEPHRIN EXPRESSION | FOCAL SEGMENTAL GLOMERULOSCLEROSIS | Antihypertensive Agents - pharmacology | Podocytes - metabolism | Angiotensin II - metabolism | Rats, Transgenic | Membrane Proteins - genetics | Humans | Kidney Failure, Chronic - drug therapy | RNA, Messenger - genetics | Rats, Inbred F344 | Angiotensin II - antagonists & inhibitors | Rats | Male | Kidney Glomerulus - pathology | Podocytes - pathology | RNA, Messenger - metabolism | Rats, Sprague-Dawley | Kidney Failure, Chronic - metabolism | Kidney Failure, Chronic - genetics | Animals | Podocytes - drug effects | Kidney Failure, Chronic - pathology | Kidney Glomerulus - metabolism | Intracellular Signaling Peptides and Proteins - genetics | Disease Models, Animal
Journal Article
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, ISSN 1569-1993, 08/2019
The majority of nontuberculous mycobacterial (NTM) pulmonary infections in people with cystic fibrosis (CF) are caused by Mycobacterium avium complex (MAC)...
Journal Article
Pharmaceutical Research, ISSN 0724-8741, 1/2019, Volume 36, Issue 1, pp. 1 - 11
To improve cytometric phenotyping abilities and better understand cell populations with high interindividual variability, a novel Raman-based microanalysis was...
Biochemistry, general | Biomedicine | lipid-laden foamy macrophages | Pharmacy | intracellular drug bioaccumulation | Medical Law | confocal Raman microscopy | pulmonary alveolar macrophages | Pharmacology/Toxicology | Biomedical Engineering and Bioengineering | single-cell chemical imaging | CELLS | PULMONARY TOXICITY | COMPONENT ANALYSIS | MICROSPECTROSCOPY | CHEMISTRY, MULTIDISCIPLINARY | AMINE-CONTAINING DRUGS | INDUCED PHOSPHOLIPIDOSIS | SPECTROSCOPY | SCATTERING MICROSCOPY | IN-VIVO | ALVEOLAR MACROPHAGES | PHARMACOLOGY & PHARMACY | Macrophages | Algorithms | Drug discovery | Populations | Chloroquine | Feasibility studies | Data processing | Lipids | Organic chemistry | Cytometry | Toxicology | Cargo capacity | Phase separation | Phenotyping | Signal processing | Biomolecules | Chemical composition | Intracellular | Alveoli | Content analysis
Biochemistry, general | Biomedicine | lipid-laden foamy macrophages | Pharmacy | intracellular drug bioaccumulation | Medical Law | confocal Raman microscopy | pulmonary alveolar macrophages | Pharmacology/Toxicology | Biomedical Engineering and Bioengineering | single-cell chemical imaging | CELLS | PULMONARY TOXICITY | COMPONENT ANALYSIS | MICROSPECTROSCOPY | CHEMISTRY, MULTIDISCIPLINARY | AMINE-CONTAINING DRUGS | INDUCED PHOSPHOLIPIDOSIS | SPECTROSCOPY | SCATTERING MICROSCOPY | IN-VIVO | ALVEOLAR MACROPHAGES | PHARMACOLOGY & PHARMACY | Macrophages | Algorithms | Drug discovery | Populations | Chloroquine | Feasibility studies | Data processing | Lipids | Organic chemistry | Cytometry | Toxicology | Cargo capacity | Phase separation | Phenotyping | Signal processing | Biomolecules | Chemical composition | Intracellular | Alveoli | Content analysis
Journal Article